 |
Member
|
|
Join Date: Nov 2011
Location: Marysville, WA
Posts: 613
|
|
|
Member
Join Date: Nov 2011
Location: Marysville, WA
Posts: 613
|
Quote:
Originally Posted by Tupelo3
New details learned about a key cellular protein could lead to treatments for neurodegenerative diseases, such as Parkinson's, Huntington's, Alzheimer's, and amyotrophic lateral sclerosis (ALS). In a new study, researchers in the laboratory of Steven Finkbeiner, MD, PhD, at the Gladstone Institutes used a different protein, Nrf2, to restore levels of the disease-causing proteins to a normal, healthy range, thereby preventing cell death.
The researchers tested Nrf2 in two models of Parkinson's disease: cells with mutations in the proteins LRRK2 and α-synuclein. By activating Nrf2, the researchers turned on several "house-cleaning" mechanisms in the cell to remove excess LRRK2 and α-synuclein."Nrf2 coordinates a whole program of gene expression, but we didn't know how important it was for regulating protein levels until now"
Single protein may hold secret to treating Parkinson's disease and more | EurekAlert! Science News |
Some Nfr2 activators are DHA, Gastrodin, Sulforaphane from broccoli, Pterostilbene, Curcumin, Green tea, Milk thistle, Bacopa, and Ashwagandha.
__________________
Born 1948. Diagnosed 2011. DBS ON 7/17. Taking cd/ld 200 MG at 6 am, 9 am, 12 pm, 3 pm, 6 pm and 9 pm. Finasteride 5 mg, Life Extension Mix and Once-Daily Health Booster, Mitochondrial Energy Optimizer with BioPQQ, Optimized Curcumin (longvida), Triple Action Cruciferous Vegetable Extract with Resveratrol, Vectomega-3, Vit D3 5000U,Lithium orotate 5 mg, AMPK Activator, Kefiran, N-Acetyl-L- Cysteine (NAC), Tri-Magnesium, Advanced NeuroPro, Duozyme,
Palmitoylethanolamide (PEA) Updated 9/21/17.
|